Profilo
Alan Mendelsohn worked as a Senior Director in Immunology Research & Development at Johnson & Johnson from 2006 to 2014.
He then worked as a Senior Director at Pfizer Inc. from 2014 to 2016.
From 2016 to 2021, he worked as an Associate VP in Dermatology Medical Affairs at Sun Pharmaceutical Industries Ltd. Currently, he is the Chief Medical Officer & Executive Vice President at Timber Pharmaceuticals, Inc. Dr. Mendelsohn earned a doctorate degree from the State University of New York at Downstate Medical Center.
Precedenti posizioni note di Alan Mendelsohn
| Società | Posizione | Fine |
|---|---|---|
| TREX WIND-DOWN, INC. | Direttore Tecnico/Scientifico/R&S | 22/01/2024 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | 01/02/2021 |
| PFIZER INC. | Direttore/Membro del Consiglio | 01/12/2016 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2014 |
Formazione di Alan Mendelsohn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical ingredients | Health Technology |
State University of New York at Downstate Medical Center
State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes therapies for treatment of orphan dermatologic diseases | Health Technology |
















